Dr. Sun joined Fidelity Biosciences in 2012. Prior to joining, Dr. Sun was a Senior Associate Consultant at L.E.K. Consulting in the healthcare practice. At L.E.K. Consulting, Dr. Sun specialized in corporate growth strategies, portfolio management, commercial opportunity assessment, competitive analysis and M&A advisory for large pharmaceutical and medical device companies, as well as leading private equity firms.
Dr. Sun holds a Ph.D. in Molecular Pharmacology from Stanford University School of Medicine. His graduate research was focused on developing novel therapeutics for heart attack and congestive heart failure. He received his B.S. in Biology with Distinction from Yale University.